Source: Pharmacy Times articles
A recent study highlights the promising immune response and safety of the Arexvy vaccine in lung transplant recipients, crucial for preventing RSV infections.
Read More
by MM360 Staff | May 9, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
A recent study highlights the promising immune response and safety of the Arexvy vaccine in lung transplant recipients, crucial for preventing RSV infections.
Read More